Damning Investigation Shows Big Pharma Bribed 68,000 Doctors To Push Deadly Opioids

(Natural Blaze by Claire Bernish) More than 68,000 doctors received payments in excess of $46 million — in the span of just 29 months — from Goliath pharmaceutical corporations pushing opioid painkillers, researchers in a groundbreaking investigation of Big Pharma’s and the epidemic of legal and illicit opiates plaguing the United States.

Money to push opioids found one doctor in 12, and the rampant destruction wrought upon countless American families forced to cope with loved ones dependent on prescription painkillers, or on heroin sought when those ran out, proves circumstantially the dollars did their job.

“The next step is to understand these links between payments, prescribing practices, and overdose deaths,” Scott Hadland, a pediatrician and author of the study, published in the American Journal of Public Healthtold the Washington Post.

Averaged out, more than 1,000 people suffered fatal drug overdoses per week in 2015, the Centers for Disease Control and Prevention reported, and steep spike occurred during the first six months of the following year — which the National Centers for Health Statistics attributes largely to a sharp rise opioid deaths — in particular, heroin and the potent synthetic painkiller, fentanyl.

Despite heroin driving that abrupt increase, Hadland points out that, for many,

It’s very common that the first opioid they’re ever exposed to is from a prescription.

Indisputably, the opioid crisis presents a quagmire of issues, each seeming to perpetuate others; and while its complexities seem monumental, the twin agitators of pharmaceutical money to physicians to push dangerous painkillers and the multifarious war on drugs — especially federal prohibition of cannabis, which helps alleviate dependency — present the simplest avenues to explore solutions.

To wit, Boston Medical Center researchers found the largest sums were given to doctors to push fentanyl — a painkiller anywhere from 50 to 100 times stronger than morphine, used for the extreme pain of cancer, end of life, and more. Illicit fentanyl manufactured overseas is cut into heroin — when can overwhelm the user’s system with a lethal cocktail of opioids and synthetics.

Drug developers engineered tamper-proof fentanyl pills in response to the epidemic, but the study found pharmaceutical companies, on the whole, were not aggressively marketing those safer versions to doctors.

According to the investigation, the top 1 percent of physicians, around 700, received 82.5 percent of total sum of payments for opioids. Speaking fees constituted approximately two-thirds of the total dollars Big Pharma bestowed to physicians, but pharmaceutical reps wined and dined doctors more than any other courting activity, constituting just under 94 percent of total payouts.

Incidentally, the analysis of public data from Centers for Medicare and Medicaid Services revealed, Big Pharma opioid money inundated every corner of the U.S.; but, Indiana, Ohio, and New Jersey — the three states bearing the harrowing brunt of the nationwide opioid scourge — recorded the largest number of payments to doctors.

That this study is believed the first of its kind — coupled with its focus on pharmaceutical opioid cash — speaks to the influence those millions upon millions each year tragically outscream the mourning throngs of families whose loved ones originally sought only to alleviate untenable pain.

Corporate media and pharmaceutical marketers have muddied potential solutions in proposals to solve the nation’s pill problem with yet more pills — or their equivalent — legalization of cannabis, found to treat opiate addiction, would do more to extricate opioid addicts from their potentially fatal substance dependency than nearly any other option.

Study authors conclude, “These findings should prompt an examination of industry influences on opioid prescribing” — a study the mounting scores of dead attest should have been undertaken years ago.

Claire Bernish began writing as an independent, investigative journalist in 2015, with works published and republished around the world. Not one to hold back, Claire’s particular areas of interest include U.S. foreign policy, analysis of international affairs, and everything pertaining to transparency and thwarting censorship. To keep up with the latest uncensored news, follow her on Facebook or Twitter: @Subversive_Pen. This article first appeared at The Free Thought Project.

Recommended Reading:

Dementia Now the Top Cause of Death Among Women in the UK

(Natural News) A recent report by the Public Health England revealed that Alzheimer’s disease and dementia are now the leading causes of death among women in the United Kingdom. According to the report, the country’s overall life expectancy for women has shown a significant increase in years, which is now 83.1 years. However, these added years are characterized by poor health. As per the report, women are expected to live about a quarter of their lives being ill.

The report also noted that while other diseases exhibited a relative decline, the rates of Alzheimer’s disease and dementia have doubled since 2001. In fact, the cognitive diseases were accounted for 15.3 percent of deaths among British women.

Related Reading: Increase Your Cognitive Power – A Simple User’s Manual For Your Brain

“Good public health is not defined by health policy alone. Our health profiles show a high-quality education, a well-designed and warm home, a good job, and a community to belong to are just as important. The more we consider the impact of all policies on population health, the sooner we can focus on preventing poor health instead of only dealing with its consequences, especially for those from the most deprived communities,” Duncan Selbie, chief executive of Public Health England, was quoted as saying on The Daily Express website.

“To achieve the same successes as we have with other health conditions like heart disease and cancer, we need dementia research to remain a national priority. We have been able to make promising steps forward, thanks to a renewed focus, but we are not there yet,” said Dr. Matthew Norton, director of policy at Alzheimer’s Research U.K.

The latest figure was consistent with an Office for National Statistics report released late last year. According to the report, more women died from Alzheimer’s disease and dementia in 2015 compared with men. Report data showed that the cognitive conditions accounted for 41,283 dementia deaths in women in 2015, which equates to 15.2 percent of all female deaths in that year. This was significantly higher than the 13.4 percent recorded in 2014.

Related: Beat Alzheimer’s Disease Naturally

“These figures once again call attention to the uncomfortable reality that currently, no one survives a diagnosis of dementia. Dementia is not an inevitable part of ageing, it’s caused by diseases that can be fought through research, and we must bring all our efforts to bear on what is now our greatest medical challenge,” Alzheimer’s Research U.K. official Hilary Evans told BBC.com.

Are vaccines to blame for the increasing rates of dementia?

Exposure to heavy metals — such as mercury and aluminum — by way of vaccines and medicines have long been associated with an increased risk of developing dementia and other neurological conditions. In fact, an analysis published in the Journal of Alzheimer’s Disease revealed that long-term mercury exposure was linked to the onset of Alzheimer’s disease symptoms including confusion, impaired memory, and cognitive function decline. Mercury was mostly used as a preservative in many childhood vaccines until 2001.

Related: The Alzheimer’s Aluminum Connection

On the other hand, a study published in 2009 revealed that aluminum, another heavy metal commonly added to flu shots, may raise the odds of developing dementia and other neurological conditions. According to the study, people who had the highest aluminum content in their drinking water had the highest risk of suffering from the condition. A vast number of clinical studies have also shown that the heavy metal was directly tied to the onset of brain damage. (Related: Aluminum in vaccines linked to Alzheimer’s and other neurological conditions.)

Related Reading:
Sources include:

 

Canadians Are Unknowingly Eating GM Salmon

(Natural Blaze) Ottawa – August 7, 2017 – AquaBounty revealed on August 4, in its quarterly financial results, that it has sold approximately five tonnes of genetically modified (GM or genetically engineered) Atlantic salmon fillets in Canada. (1) This is the world’s first sale of GM fish for human consumption and has occurred without GM product labeling for Canadian consumers.

Related: Genetically Modified Salmon Is On Its Way To Your Store

“No one except AquaBounty knows where the GM salmon are,” said Lucy Sharratt of the Canadian Biotechnology Action Network (CBAN). “The company did not disclose where the GM salmon fillets were sold or for what purpose, and we’re shocked to discover that they’ve entered the market at this time.”

Without mandatory labeling in Canada, CBAN works to track GM foods to keep Canadians informed.

“The immediate remedy is for grocery stores to commit to keeping GM salmon out,” said Sharratt. So far, two grocery companies in Canada have published statements online responding to consumer concerns over GM salmon: IGA Quebec states that it only orders non-GM salmon, and Costco’s website states that it does not intend to sell it.(2)

“We clearly need mandatory labeling of all GM foods,” said Thibault Rehn of the Quebec network Vigilance OGM, a member group of CBAN.

Related: What Do Natural, Organic, and Non-GMO Actually Mean?

There is no federal government tracking of GM products in the market and Members of Parliament voted down a Private Members Bill for mandatory GM food labeling in May. GM salmon is approved for human consumption in the US and Canada, but there is an import ban in the US until labeling guidelines are published.

“When it comes to GM foods, Canadian consumers are shopping blind,” said Sharratt.

NOTES:
(1) AquaBounty Technologies, Inc. Quarterly Filing, 10-Q, 08/04/17  http://phx.corporate-ir.net/phoenix.zhtml?c=197553&p=irol-sec#15145522

(2) IGA Quebec: “Non-GMO salmon: At IGA, we order only non-GMO salmon from our suppliers, even though genetically modified salmon is legal and approved by the Canadian Food Inspection Agency (CFIA).” https://www.iga.net/en/in_the_community/buying/sustainable_fishing
Costco: “Costco does not intend to sell genetically modified salmon.” https://www.costco.com/sustainability-fisheries.html

For the First Time, NFL Acknowledges Benefits of Cannabis, Offers to Study it for Pain

Doping in sports and steroid abuse concept with a american football, a bottle of prescription pills and syringes with green and red liquid on a dark background

(The Free Thought Project) The NFL is finally acknowledging that cannabis has the potential to treat acute and chronic pain. A report out today says that the NFL has sent a letter to the Player’s Association (NFLPA) indicating it is willing to study the use of medical cannabis for pain management.

The NFLPA, apparently quicker to grasp the conclusions of science, is already studying the issue. In Jan. 2017, the National Academies of Science (NAS) released an exhaustive study on the therapeutic benefits of cannabis, with chronic pain treatment being one of the most significant.

Related: Why Chronic Pain is Such a Pain and What You Can Do About It

Players in America’s favorite sport are plagued by pain, often for the rest of their lives, and many have already turned to medical cannabis whether the league allows it or not. Soon after the NAS study, retired football players were telling their stories of lives virtually ruined by pain and the standard drugs given to them such as opioid pills – only to find relief with cannabis.

Now, former NFL players are trying to open medical cannabis dispensaries and extolling the benefits of this medicinal plant. They are on the right side of history, and the NFL may finally be catching up.

Cannabis use remains banned by the league, with players regularly tested and penalized if THC is detected. At the moment, the NFL is still stuck in the Reefer Madness mentality, thinking that because federal government prohibits the plant, then they should as well. But the letter to the NFLPA is an encouraging sign.

We look forward to working with the Players Association on all issues involving the health and safety of our players,” said Joe Lockhart, the NFL’s executive vice president of communications…

The NFL, according to one person with knowledge of the matter, wrote a letter to the union asking if, given the NFLPA’s public comments on the issue this year, it is interested in working together on research. The league’s letter outlined a few areas for potential research that included pain management for both acute and chronic conditions.”
The NFLPA is also seeking to reduce punitive measures for the use of cannabis, which is especially needed now that recreational cannabis is legal in eight states and 26 other states have legalized medical use only.

I do think that issues of addressing it more in a treatment and less punitive measure is appropriate,” said DeMaurice Smith, NFLPA’s executive director. “I think it’s important to look at whether there are addiction issues. And I think it’s important to not simply assume recreation is the reason it’s being used.”

The issue of opioid abuse is another reason why the NFL should adopt a more reasonable approach to medical cannabis. Opiates are routinely handed out to players for acute and chronic pain, making them prone to join the ever-growing ranks of those addicted to these dangerous legal drugs. We know from multiple studies that people are giving up deadly, addictive opioids in favor of cannabis in states where it is legal.

In addition to a safer method of pain management, medical cannabis can help prevent brain damage, which is also pervasive in NFL players. A recent major study found that “a vast majority of the brains of deceased players that were studied showed signs of chronic traumatic encephalopathy, a degenerative condition linked to head trauma.”

Related: The Gut-Brain Connection

In response to this, Doctors for Cannabis Regulation is lobbying the NFL to change its irrational rules on cannabis. It should be noted that medical cannabis can be administered with no psychoactive effects.

There is some early data that cannabis does play a role in neuroprotection. This is the kind of science we’ve put in front of the NFL, hoping they would reconsider their antiquated policies,” Dr. Suzanne Sisley told The Chronicle. “The bottom line is that cannabinoids are clearly neuroprotective. We have preclinical data at the receptor level that cannabinoids and cannabis are not only involved with brain repair but neurogenesis, the development of new neural tissue. It’s one of the most exciting discoveries of modern neuroscience.”

The NFL appears to have taken the first step in embracing factual evidence and science. Hopefully this will continue, as other entities such as Big Pharma and the alcohol industry will surely lobby against relaxing the NFL’s current prohibitionist stance.

Depression Doubles the Risk of Death From Coronary Artery Disease, Finds Research

(Independent) Depression appears to double the chance of dying in any given year for patients with coronary artery disease, according to a new study.

 The researchers said such mental distress was a “stronger risk factor” than age, having had a heart attack, or diabetes.
Related: Lower Cholesterol and prevent Heart Disease Without Drugs
The effect was seen if the person was depressed before or after diagnosis of the disease.

Dr. Heidi May, a cardiovascular epidemiologist at Intermountain Medical Centre Heart Institute in Salt Lake City, said: No matter how long or how short it was, patients were found to have twice the risk of dying compared to those who didn’t have a follow-up diagnosis of depression.

Depression was the strongest risk factor for dying, compared to any other risk factors we evaluated. That included age, heart failure, diabetes, high blood pressure, kidney failure, or having a heart attack or stroke.

We’ve completed several depression-related studies and been looking at this connection for many years.

The data just keeps building on itself, showing that if you have heart disease and depression and it’s not appropriately treated in a timely fashion, it’s not a good thing for your long-term wellbeing.”

Of more than 2,600 patients who became clinically depressed about 27 per cent did so within a year of being diagnosed with the disease. The figure was 37 per cent after five years.

And while depression seems to make the condition worse, being diagnosed is also a reason why some patients become depressed.

The reason why the chance of dying increased was not revealed by the study, but Dr. May said it was possible patients were not following their treatment plans as closely as people in good mental health. She said,

We know people with depression tend to be less compliant with medication on average and probably in general aren’t following healthier diets or exercise regimens.

They tend to do a poorer job of doing things that are prescribed than people without depression. That certainly doesn’t mean you’re depressed so you’re going to be less compliant, but in general, they tend to follow those behaviours.”

 She added that depression can also cause physiological changes to the body, which could also be a factor.
Related: Natural Approaches to Combat Depression

Dr. May urged the medical community to take depression seriously when treating coronary artery disease.

Patients who have depression need to be treated to improve not only their long-term risks but their quality of life.”